Ambrosia Biosciences News and Activities

Acquisition, funding and merger involving Ambrosia Biosciences.

• Ambrosia Biosciences has just announced a $100 Million fundraising (posted on April 6 2026).

View the org chart displaying its 18 main executives

Most searched biographies at Ambrosia Biosciences

• Nick Traggis, Chief Executive Officer
• Sara Clarke, Director
• Jason Haddock, Director

Popular executive movements at Ambrosia Biosciences

• Sara Clarke has joined the company as Director  (posted on April 6 2026).

Create your alert
to follow the executive moves at Ambrosia Biosciences.

Ambrosia Biosciences has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Ambrosia Biosciences

Social media about Ambrosia Biosciences

• Ambrosia Biosciences on Wikipedia, Google News & Yahoo Finance
• Ambrosia Biosciences on LinkedIn, X (Twitter) & YouTube